-
Goodbye BMI? Why Body Composition Is Gaining Ground in Clinics
The rise of incretin-based therapies for obesity care, like Wegovy (semaglutide) and Zepbound (tirzepatide), has brought renewed attention to the risk of muscle atrophy that can accompany rapid weight loss. To better assess…
-
Obesity Redefined: A Bold New Approach to Diagnosis
A recent publication in The Lancet: Diabetes & Endocrinology is prompting the medical community to rethink how obesity is screened and diagnosed. Endorsed by over 75 organizations worldwide, including scientific societies and patient…
-
Dizziness and Wegovy: What’s the Connection?
I’ve recently had an increasing number of patients report dizziness while taking Wegovy (semaglutide). This has been observed in both newly prescribed patients and those who have been on the medication for over…
-
Cortisol and Weight Gain: How Stress Affects Your Body
Cortisol has become a prominent topic in discussions about weight loss. Often referred to as the “fight or flight” hormone, it is closely associated with stress. Recently, many health and wellness influencers have…
-
Your Weight Matters: Key Messages from the National Convention
This summer Denver hosted it’s first 4-day educational event for individuals concerned with weight-related issues. The Your Weight Matters National Convention is the largest National meeting dedicated to providing evidence-based strategies for individuals impacted…
Diabetes Care and Education
